G. Creasy

发表

Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women.

A. Fisher, D. Archer, A. Bigrigg, 2002, Fertility and sterility.

The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy.

A. Fisher, D. Archer, G. Creasy, 2004, Contraception.

Gastric dysrhythmias and nausea of pregnancy

R. Stern, K. Koch, M. Vasey, 1990, Digestive Diseases and Sciences.

Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data.

K. Nicolaides, R. Romero, Z. Alfirevic, 2012, American journal of obstetrics and gynecology.

Endometrial morphology in asymptomatic postmenopausal women.

M. Kafrissen, D. Archer, G. Creasy, 1991, American journal of obstetrics and gynecology.

First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics

B. Friedland, L. Novak, N. Teleshova, 2016, Journal of acquired immune deficiency syndromes.

Transdermal contraception: evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study.

A. Fisher, J. Rosen, G. Shangold, 2002, American journal of obstetrics and gynecology.

Review of the endometrial effects of estrogens and progestins.

M. Kafrissen, D. Upmalis, G. Creasy, 1992, Obstetrical & gynecological survey.

Endocrine/reproductive pulsatile delivery systems

G. Creasy, M. Jaffe, 1991 .

Pulsatile Delivery Systems

G. Creasy, M. Jaffe, M. Jaffe, 1991, Annals of the New York Academy of Sciences.

The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.

T. Goodwin, G. Valenzuela, R. Chez, 1994, American journal of obstetrics and gynecology.

Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.

J. Hobbins, W. Rayburn, R. Romero, 2000, American journal of obstetrics and gynecology.

Dose Ranging Study of the Oxytocin Antagonist Atosiban in the Treatment of Preterm Labor

T. Goodwin, G. Valenzuela, G. Creasy, 1996 .

Topical tretinoin and vaginal bleeding.

E. Thorne, G. Creasy, S. Worobec, 1991, Annals of internal medicine.

Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol.

D. Archer, R. Sitruk-Ware, J. Conard, 2016, Contraception.

A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra).

B. Sibai, A. Fisher, V. Odlind, 2002, Fertility and sterility.

Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double‐blind, placebo‐controlled trial

E. DeFranco, D. Lewis, C. Adair, 2009, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Conception rates in clomiphene citrate cycles with and without hormone supplementation: a pilot study

K. Elkind-Hirsch, G. Creasy, D. Gipe, 2005, Current medical research and opinion.

An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.

R Lane, B. Sibai, R. Romero, 2000, American journal of obstetrics and gynecology.

Effects of concurrent vaginal miconazole treatment on the absorption and exposure of Nestorone® (segesterone acetate) and ethinyl estradiol delivered from a contraceptive vaginal ring: a randomized, crossover drug-drug interaction study.

Leo Han, Narender Kumar, K. Simmons, 2017, Contraception.

Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta‐analysis of individual patient data

Roberto Romero, Kypros H. Nicolaides, Sonia S. Hassan, 2017, American journal of obstetrics and gynecology.

Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

B. Friedland, G. Creasy, S. Mathur, 2020, BMJ Sexual & Reproductive Health.

Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.

G. Hammond, P. Siiteri, J. Natarajan, 2003, Contraception.

Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double‐blind, placebo‐controlled trial

L. Sullivan, R. Romero, S. Hassan, 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data.

A. Fisher, E. Weisberg, J. Guillebaud, 2002, Fertility and sterility.

Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions.

A. Fisher, H. Zacur, B. Hédon, 2001, Fertility and sterility.

Pharmacokinetics of Norelgestromin and Ethinyl Estradiol Delivered by a Contraceptive Patch (Ortho Evra™/Evra™) under Conditions of Heat, Humidity, and Exercise

J. Natarajan, F. Wong, P. Leese, 2001, Journal of clinical pharmacology.

Efficacy and Safety of a Transdermal Contraceptive System

A. Fisher, J. Lenihan, Geoffrey H Smallwood, 2001, Obstetrics and gynecology.

A comparative assessment of ORTHO EVRA™/EVRA™ to placebo patch effects on body weight.

B. Sibai, A. Fisher, V. Odlind, 2001 .

Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial.

A. Fisher, W. Koltun, A. Waldbaum, 2001, JAMA.

Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error.

R. Pierson, A. Fisher, D. Archer, 2003, Fertility and sterility.

Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.

A. Fisher, G. Shangold, G. Creasy, 2003, The Journal of reproductive medicine.

Patient adherence with the contraceptive patch dosing schedule versus oral contraceptives

G. Creasy, 2000 .

Comparison of efficacy, cycle control, compliance, and safety in users of a contraceptive patch vs an oral contraceptive

A. Fisher, F. Helmerhorst, B. Hédon, 2000 .

Transdermal Contraception

A. Fisher, G. Creasy, L. Abrams, 2001, Seminars in reproductive medicine.

A Zomepirac Reaction Mimicking Ectopic Pregnancy

G. Creasy, M. Kousen, W. Walker, 1984, Drug intelligence & clinical pharmacy.

Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double‐blind, placebo‐controlled trial

J. Weeks, E. DeFranco, D. Lewis, 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double‐blind, placebo‐controlled trial

J. Weeks, E. De Franco, D. Lewis, 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: A multicenter, randomized, double-blind, placebo-controlled trial

L. Sullivan, R. Romero, S. Hassan, 2011 .

Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta‐analysis

Roberto Romero, Kypros H. Nicolaides, Sonia S. Hassan, 2018, American journal of obstetrics and gynecology.

Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.

T. Goodwin, G. Valenzuela, G. Creasy, 1996, Obstetrics and gynecology.

Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta‐analysis including data from the OPPTIMUM study

K. Nicolaides, R. Romero, S. Hassan, 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis.

K. Nicolaides, R. Romero, Z. Alfirevic, 2013, American journal of obstetrics and gynecology.

Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel

B. Friedland, Yupu Liang, R. Fichorova, 2022, PloS one.

In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa

B. Friedland, G. Villegas, G. Calenda, 2016, Antimicrobial Agents and Chemotherapy.

Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation.

K. Barnhart, I. Fraser, M. Gilliam, 2019, Contraception.

Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20.

A. Fisher, C. Bouchard, G. Shangold, 2001, Contraception.

Maternal Liver Hemangioma In Pregnancy as an Incidental Finding

G. Creasy, Fred Fuckinger, Richard Kraus, 1985, Obstetrics and gynecology.